<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00510744</url>
  </required_header>
  <id_info>
    <org_study_id>PRO07070305</org_study_id>
    <nct_id>NCT00510744</nct_id>
  </id_info>
  <brief_title>Pancreatic Enzymes to Restore Digestive Function in Malnourished Gastric Bypass Patients</brief_title>
  <official_title>Pancreatic Enzymes to Restore Digestive Function in Malnourished Gastric Bypass Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Solvay Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis: Bypass of the upper GI tract with bariatric surgery results in suppression of&#xD;
      pancreatic function resulting in maldigestion and further malabsorption. In this study we&#xD;
      will measure pancreatic secretion in previously obese gastric bypass patients with excessive&#xD;
      weight loss. If malabsorption is associated with diminished pancreatic secretion, we will&#xD;
      test over a 3 month period whether supplementation with enzyme supplements prevent further&#xD;
      weight loss.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obesity has reached epidemic proportions in the USA and Europe, and is increasing world-wide.&#xD;
      Morbid obesity (BMI&gt;40kg/m2) is usually resistant to medical and dietary therapy while&#xD;
      surgical treatment results in a permanent loss of most of the excess weight. The most popular&#xD;
      technique today is the Roux-en-Y gastric bypass procedure which results in a weight loss of&#xD;
      approximately 95 lbs per year or a 2/3 loss of the excess weight in 2 years (7-9). Weight&#xD;
      loss occurs for 2 reasons: first the volume of the stomach is reduced, and second, the&#xD;
      duodenum and first part of the jejunum is bypassed resulting in malabsorption. Although most&#xD;
      patients tolerate the procedure well with a leveling off of weight loss close to the ideal&#xD;
      body weight, a subpopulation of patients continue to lose weight, becoming progressively more&#xD;
      malnourished, necessitating reversal of the surgery. To date, no studies have investigated&#xD;
      what happens to pancreatic function in obese patients following bypass surgery, but from an&#xD;
      understanding of the physiology of pancreatic stimulation, it is likely that the pancreas&#xD;
      atrophies because the intestinal phase of pancreatic stimulation is bypassed and the&#xD;
      inhibitory ileal brake is perpetually stimulated. In the following study we plan to&#xD;
      investigate whether patients with excessive weight loss after bypass surgery develop&#xD;
      malabsorption not only due to bypass of the upper GI tract but also because of impaired&#xD;
      pancreatic enzyme secretion resulting from chronic activation of the ileal brake mechanism.&#xD;
      Up to 20 post-bariatric surgery (Roux-en-Y) patients with excessive and continued weight loss&#xD;
      will be screened for fat absorption and loss of pancreatic secretion. Those with loss of &gt;20%&#xD;
      fat absorption will then be treated at home with pancreatic enzyme supplements for a 3 month&#xD;
      period to assess weight stabilization or gain. After 3 months, fat absorption and the&#xD;
      pancreatic stimulation test will be repeated while patients are on enzyme supplementation to&#xD;
      determine whether fat digestion and absorption has improved from baseline.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fat Absorption</measure>
    <time_frame>3 months</time_frame>
    <description>72 hour fat absorption study</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>pancreatic enzyme supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 month supplementation in those gastric bypass patients shown to have a fat absorption less than 80%</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>pancreatic enzyme supplement</intervention_name>
    <description>4 caps with meals, 2 with snacks</description>
    <arm_group_label>pancreatic enzyme supplementation</arm_group_label>
    <other_name>Creon</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or female adults &gt;18yrs&#xD;
&#xD;
          2. h/o Roux-en-Y gastric bypass procedure&#xD;
&#xD;
          3. Pre-surgery BMI &gt;40Kg/m2&#xD;
&#xD;
          4. Weight loss of &gt;30%, or 100lbs in 1st year following bypass surgery&#xD;
&#xD;
          5. Able to consume normal requirement levels of food. This will be determined from&#xD;
             history (see above) and confirmed during the 72h food-balance study in the GCRC.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Chronic pancreatic disease as evidenced by history, pancreatic imaging (CT or MRP&#xD;
             scanning or ERCP) or alcohol abuse (&gt;3 units of alcohol/day) as documented by family&#xD;
             or care givers&#xD;
&#xD;
          2. h/o intestinal resection other than gastric bypass&#xD;
&#xD;
          3. Unstable cardio-respiratory status (BP diastolic &gt;100mmHg, systolic &gt;200 or &lt;80 mmHg),&#xD;
             ambient pO2 &lt;90%&#xD;
&#xD;
          4. Presence of chronic inflammatory bowel or chronic small intestinal mucosal disease&#xD;
             confirmed by radiology and biopsy.&#xD;
&#xD;
          5. Current history of feeding disorder, such as bulimia nervosa. This will be excluded by&#xD;
             the interview and attestation of spouses, close relatives, or home companions&#xD;
&#xD;
          6. Pregnant women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen J O'Keefe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Pittsburgh GCRC</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <study_first_submitted>August 1, 2007</study_first_submitted>
  <study_first_submitted_qc>August 1, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 2, 2007</study_first_posted>
  <results_first_submitted>April 26, 2016</results_first_submitted>
  <results_first_submitted_qc>April 26, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 2, 2016</results_first_posted>
  <last_update_submitted>April 26, 2016</last_update_submitted>
  <last_update_submitted_qc>April 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 2, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Stephen O'Keefe</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>obesity, bariatric surgery, pancreatic secretion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Malnutrition</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>with publication</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Pancreatic Enzyme Supplementation</title>
          <description>3 month supplementation in those gastric bypass patients shown to have a fat absorption less than 80%&#xD;
pancreatic enzyme supplement: 4 caps with meals, 2 with snacks</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Pancreatic Enzyme Supplementation</title>
          <description>3 month supplementation in those gastric bypass patients shown to have a fat absorption less than 80%&#xD;
pancreatic enzyme supplement: 4 caps with meals, 2 with snacks</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="5"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49" lower_limit="22" upper_limit="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Fat Absorption</title>
        <description>72 hour fat absorption study</description>
        <time_frame>3 months</time_frame>
        <population>each patients as their own control, baseline fat absorption vs post 3 month enzyme supplementation fat absorption</population>
        <group_list>
          <group group_id="O1">
            <title>Pancreatic Enzyme Supplementation</title>
            <description>3 month supplementation in those gastric bypass patients shown to have a fat absorption less than 80%&#xD;
The ability of pancreatic enzyme supplement: 4 caps with meals, 2 with snacks to improve fat absorption</description>
          </group>
        </group_list>
        <measure>
          <title>Fat Absorption</title>
          <description>72 hour fat absorption study</description>
          <population>each patients as their own control, baseline fat absorption vs post 3 month enzyme supplementation fat absorption</population>
          <units>g/d</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.6" spread="13.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>paired changes in fat absorption assessed by parametric (t test) or non-parametric tests (Mann-Whitney)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.2</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>24</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Pancreatic Enzyme Supplementation</title>
          <description>3 month supplementation in those gastric bypass patients shown to have a fat absorption less than 80%&#xD;
pancreatic enzyme supplement: 4 caps with meals, 2 with snacks</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Stephen O'Keefe</name_or_title>
      <organization>University of Pittsburgh</organization>
      <phone>412 648 7217</phone>
      <email>sjokeefe@pitt.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

